VITOC VLAD (Chief Executive Officer) purchased 1.5% of their position (11.80K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $11.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/25/2025ACC: 0001878313-25-000040
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2022
+11.80K
Net shares
Net buyer
$11.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
11.80K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.80K
Price / share
$0.92
Trade value
$1.66K
% of position
0.2%
11/21/2025
809.12K→810.92K
Common Stock
Direct
Shares
+10K
Price / share
$0.99
Trade value
$9.89K
% of position
1.2%
11/24/2025
810.92K→820.92K
Total
Net shares
+11.80K
Net value
$11.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | P · Purchase | +1.80K | $0.92 | $1.66K | 0.2% | 809.12K | 810.92K |
| Common Stock Direct | 11/24/2025 | P · Purchase | +10K | $0.99 | $9.89K | 1.2% | 810.92K | 820.92K |
| Total | +11.80K | $11.55K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned210.10K
Total
210.10K indirect210.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 210.10K | Indirect |
| Total | 210.10K | 210.10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported